Endocision Technologies Inc.
$75,000.00 CAD
≈ 12 months of average Canadian pay
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2023-2024
- Agreement period
- October 2, 2023 – September 30, 2024
- Reference
- nrc-cnrc:172-2023-2024-Q3-1013144
Published purpose
Lung cancer is a leading cause of death in Canada, with a low survival rate for patients with advanced disease. The standard treatment, surgery, is invasive and risky, and contraindicated for patients with comorbidities. This project aims to develop a new device for lung lesions to provide a minimally invasive treatment option for these lesions with reduced complication risks compared to existing techniques.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported August 3, 2026 from open.canada.ca Grants & Contributions